BlackRock Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.8M | Buy |
85,199
+17,107
| +25% | +$562K | ﹤0.01% | 1518 |
|
|
2016
Q3 | $2.15M | Buy |
68,092
+3,824
| +6% | +$121K | ﹤0.01% | 1565 |
|
|
2016
Q2 | $1.81M | Buy |
64,268
+8,757
| +16% | +$246K | ﹤0.01% | 1613 |
|
|
2016
Q1 | $2.02M | Buy |
55,511
+9,213
| +20% | +$335K | ﹤0.01% | 1533 |
|
|
2015
Q4 | $1.85M | Buy |
46,298
+13,464
| +41% | +$539K | ﹤0.01% | 1517 |
|
|
2015
Q3 | $936K | Sell |
32,834
-4,355
| -12% | -$124K | ﹤0.01% | 1909 |
|
|
2015
Q2 | $1.23M | Sell |
37,189
-5,556
| -13% | -$183K | ﹤0.01% | 1831 |
|
|
2015
Q1 | $1.23M | Buy |
42,745
+21,390
| +100% | +$616K | ﹤0.01% | 1750 |
|
|
2014
Q4 | $581K | Sell |
21,355
-13,099
| -38% | -$356K | ﹤0.01% | 2169 |
|
|
2014
Q3 | $734K | Sell |
34,454
-18,296
| -35% | -$390K | ﹤0.01% | 1951 |
|
|
2014
Q2 | $1.19M | Buy |
52,750
+2,801
| +6% | +$62.9K | ﹤0.01% | 1703 |
|
|
2014
Q1 | $1.26M | Sell |
49,949
-2,769
| -5% | -$70K | ﹤0.01% | 1848 |
|
|
2013
Q4 | $1.21M | Buy |
52,718
+4,163
| +9% | +$95.7K | ﹤0.01% | 1848 |
|
|
2013
Q3 | $924K | Buy |
48,555
+6,899
| +17% | +$131K | ﹤0.01% | 1939 |
|
|
2013
Q2 | $600K | Buy |
+41,656
| New | +$600K | ﹤0.01% | 1994 |
|